[HTML][HTML] Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH

L Goedeke, GI Shulman - Molecular metabolism, 2021 - Elsevier
Background Mitochondrial uncouplers shuttle protons across the inner mitochondrial
membrane via a pathway that is independent of adenosine triphosphate (ATP) synthase …

Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH.

L Goedeke, GI Shulman - Molecular Metabolism, 2021 - europepmc.org
Background Mitochondrial uncouplers shuttle protons across the inner mitochondrial
membrane via a pathway that is independent of adenosine triphosphate (ATP) synthase …

[HTML][HTML] Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH

L Goedeke, GI Shulman - Molecular Metabolism, 2021 - ncbi.nlm.nih.gov
Background Mitochondrial uncouplers shuttle protons across the inner mitochondrial
membrane via a pathway that is independent of adenosine triphosphate (ATP) synthase …

Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH

L Goedeke, GI Shulman - Molecular metabolism, 2021 - pubmed.ncbi.nlm.nih.gov
Background Mitochondrial uncouplers shuttle protons across the inner mitochondrial
membrane via a pathway that is independent of adenosine triphosphate (ATP) synthase …

[PDF][PDF] Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH

L Goedeke, GI Shulman - 2021 - feralizedhuman.com
Background: Mitochondrial uncouplers shuttle protons across the inner mitochondrial
membrane via a pathway that is independent of adenosine triphosphate (ATP) synthase …